Additional financing propels Gelmetix into clinical trial phase for treating chronic lower back pain, with first-in-human study due to take place in France and Australia
Gelmetix won 3rd place in the final of the biotech category of the prestigious EIT Health Catapult competition
Gelmetix has received approval to launch a clinical study on the DXM Gel.
Gelmetix and Stemmatters, a Portuguese company, sign collaboration agreement for development of innovative cartilage repair device for Knee Ostearthritis
Gelexir Healthcare announces rebranding and becomes ‘Gelmetix’, in line with its new multi-product strategy
Gelmetix expands with the opening of a French subsidiary, incubated at Ecole Polytechnique, the #1 French Engineering school
Gelexir has successfully been audited by Lloyd Register Quality Assurance and obtained the ISO 13485 certification of its R&D and Manufacturing organisation.
